The estimated Net Worth of Matti Tiainen is at least $3.88 Milion dollars as of 8 June 2021. Mr Tiainen owns over 202,615 units of Pro Farm Inc stock worth over $3,880,417 and over the last 3 years he sold MBII stock worth over $0.
Mr has made over 1 trades of the Pro Farm Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 202,615 units of MBII stock worth $162,092 on 8 June 2021.
The largest trade he's ever made was exercising 202,615 units of Pro Farm Inc stock on 8 June 2021 worth over $162,092. On average, Mr trades about 101,308 units every 0 days since 2021. As of 8 June 2021 he still owns at least 4,850,521 units of Pro Farm Inc stock.
You can see the complete history of Mr Tiainen stock trades at the bottom of the page.
Matti Tiainen is the Sr. VP of International Sales at Pro Farm Inc.
Mr Tiainen is 32, he's been the Sr. VP of International Sales of Pro Farm Inc since . There are 16 older and no younger executives at Pro Farm Inc. The oldest executive at Pro Farm Group Inc is Zachary Wochok, 77, who is the Independent Director.
Matti's mailing address filed with the SEC is C/O MARRONE BIO INNOVATIONS, INC., 7780-420 BRIER CREEK PARKWAY, RALEIGH, NC, 27617-7882.
Over the last 22 years, insiders at Pro Farm Inc have traded over $9,574,054 worth of Pro Farm Inc stock and bought 9,515,326 units worth $31,165,010 . The most active insiders traders include Ag Science Llc Ospraie Mana..., Advisory Partnersardsley Pa... oraz Advisory Partners Lp Ardsle.... On average, Pro Farm Inc executives and independent directors trade stock every 49 days with the average trade being worth of $690,868. The most recent stock trade was executed by Pamela G Marrone on 6 July 2022, trading 20,000 units of MBII stock currently worth $16,000.
Marrone Bio Innovations Inc. is a growth-oriented company leading the movement to a more sustainable world through the discovery, development and sale of innovative biological products for crop protection and plant health that help customers operate more sustainably while increasing their return on investment. MBI has screened over 18,000 microorganisms, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies and natural product chemistry to rapidly develop seven product lines. Supported by a robust portfolio of over 500 issued and pending patents, MBI's currently available commercial products are Regalia®, Stargus®, Grandevo®, Venerate®, Majestene®, Haven®, Pacesetter®, Zelto® Jet-Oxide® and Jet-Ag® , with a next-generation insecticide-nematicide, a breakthrough bioherbicide and a biofumigant in the Company's product pipeline. MBI's Pro Farm Finland-based subsidiary employs a proprietary technology derived from wood waste to stimulate plant growth and improve plant health, resulting in improved yields and crop quality. Products include UBP™ 110, Foramin®, UBP™ Seed Treatment, Foramin® ST.
Pro Farm Inc executives and other stock owners filed with the SEC include: